Oral Vaccine Global Market Report 2025

Description

An oral vaccine is a form of immunization delivered through the mouth, usually as a liquid, tablet, or capsule, to trigger an immune response against targeted pathogens. It functions by introducing antigens via the gastrointestinal tract, allowing the immune system to recognize and respond to them effectively.

The primary types of oral vaccines include live attenuated vaccines, inactivated vaccines, subunit vaccines, and others. Live attenuated vaccines contain weakened forms of pathogens designed to elicit a strong immune response without causing the disease. These vaccines are used for diseases such as polio, tuberculosis, rabies, influenza, cholera, and more, and are administered by end users including hospitals, clinics, government health agencies, and other healthcare organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The oral vaccine market research report is one of a series of new reports from The Business Research Company that provides oral vaccine market statistics, including oral vaccine industry global market size, regional shares, competitors with a oral vaccine market share, detailed oral vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the oral vaccine industry. This oral vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oral vaccine market size has grown rapidly in recent years. It will grow from $3.59 billion in 2024 to $3.95 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be credited to rising investments in vaccine research and development, supportive regulatory frameworks for oral vaccine trials, increasing global travel and tourism, the need for large-scale immunization during outbreaks, and the expansion of cold chain infrastructure.

The oral vaccine market size is expected to see strong growth in the next few years. It will grow to $5.74 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to the rising global burden of infectious diseases, increasing demand for needle-free vaccine administration, higher acceptance among pediatric patients, improved patient adherence, and expansion of government immunization programs. Major trends in this period include the emergence of novel oral vaccine technologies, advancements in oral drug delivery methods, public-private sector collaborations, development of oral vaccines targeting non-traditional diseases, and innovations in encapsulation and formulation techniques.

The increasing prevalence of infectious diseases is expected to drive growth in the oral vaccine market in the coming years. Infectious diseases are caused by harmful microorganisms-such as bacteria, viruses, fungi, or parasites that can be transmitted between individuals or via the environment. Their rise is largely attributed to increased global travel, which facilitates the rapid movement of people and pathogens across borders, accelerating the spread of infections worldwide. Oral vaccines play a key role in combating infectious diseases by stimulating mucosal immunity in the gut, a primary entry point for many pathogens, providing effective protection at the site of infection. For example, according to the Health Security Agency, a UK-based government department, reported tuberculosis (TB) cases in England increased by 11.0% in 2023 compared to 2022. Consequently, the rising prevalence of infectious diseases is boosting the oral vaccine market.

Companies in the oral vaccine market are developing innovative solutions, such as second-generation oral pill vaccines, to improve immune responses and simplify administration. These pill-based vaccines are designed to enhance immunogenicity, broaden protection, and enable mass immunization without the need for needles or cold-chain storage. For instance, in March 2025, Vaxart Inc., a U.S.-based biotechnology company, initiated a Phase 1 clinical trial for its second-generation oral norovirus vaccine delivered in pill form. The trial aims to evaluate improved immune responses and safety features, addressing the global demand for accessible and effective norovirus immunization. The pill format eliminates barriers associated with injectable vaccines and supports rapid, large-scale distribution during outbreaks.

In March 2024, the International Vaccine Institute (IVI), a South Korea-based nonprofit focused on global vaccine development, partnered with Biological E. Limited to manufacture a simplified oral cholera vaccine (OCV-S) for India and international markets. Through this collaboration, IVI will provide technical expertise and support for clinical development and regulatory approvals, enabling cost-effective oral cholera vaccine production. Technology transfer is scheduled to be completed by 2025 to help meet the growing global demand driven by increasing cholera outbreaks. Biological E. Limited is an India-based oral vaccine manufacturer.

Major players in the oral vaccine market are Pfizer Inc., Johnson & Johnson, Merck & Co., Sanofi SA, AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Sinovac Biotech Ltd., Panacea Biotec Ltd., Emergent BioSolutions Inc., Zydus Lifesciences, Serum Institute of India Pvt. Ltd., Bharat Biotech Ltd., Adimmune, Haffkine Biopharmaceutical Co. Ltd., Changchun BCHT Biotechnology Co., BIBCOL, Medigen Vaccine Biologics Corp., BlueWillow Biologics Inc., BioNet Asia Co. Ltd., and Innovax.

North America was the largest region in the oral vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in oral vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the oral vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oral vaccine market consists of sales of oral booster doses, oral vaccine delivery systems, vaccine stabilizers, and mucosal immunology research tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oral Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oral vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oral vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oral vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Vaccine Type: Live Attenuated Vaccines; Inactivated Vaccines; Subunit Vaccines; Other Vaccine Types
2) By Application: Polio; Tuberculosis; Rabies; Influenza; Cholera; Other Applications
3) By End-User: Hospital ; Clinics; Government Organization; Other End-Users
Subsegments:
1) By Live Attenuated Vaccines: Oral Polio Vaccine (OPV); Rotavirus Vaccine; Oral Typhoid Vaccine; Oral Cholera Vaccine
2) By Inactivated Vaccines: Inactivated Polio Vaccine (IPV); Inactivated Cholera Vaccine; Inactivated Hepatitis A Vaccine
3) By Subunit Vaccines: Protein Subunit Vaccines; Polysaccharide Vaccines; Conjugate Vaccines
4) By Other Vaccine Types: DNA Vaccines; RNA Vaccines; Virus-Like Particle (VLP) Vaccines; Recombinant Vector Vaccines
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co.; Sanofi SA; AstraZeneca Plc; Novartis AG; GlaxoSmithKline Plc; Sinovac Biotech Ltd.; Panacea Biotec Ltd.; Emergent BioSolutions Inc.; Zydus Lifesciences; Serum Institute of India Pvt. Ltd.; Bharat Biotech Ltd.; Adimmune; Haffkine Biopharmaceutical Co. Ltd.; Changchun BCHT Biotechnology Co.; BIBCOL; Medigen Vaccine Biologics Corp.; BlueWillow Biologics Inc.; BioNet Asia Co. Ltd.; Innovax.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37844

1. Executive Summary

2. Oral Vaccine Market Characteristics

3. Oral Vaccine Market Trends And Strategies

4. Oral Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Oral Vaccine Growth Analysis And Strategic Analysis Framework

5.1. Global Oral Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Oral Vaccine Market Growth Rate Analysis
5.4. Global Oral Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Oral Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Oral Vaccine Total Addressable Market (TAM)

6. Oral Vaccine Market Segmentation

6.1. Global Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Live Attenuated Vaccines
Inactivated Vaccines
Subunit Vaccines
Other Vaccine Types
6.2. Global Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polio
Tubercolosis
Rabies
Influenza
Cholera
Other Applications
6.3. Global Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Clinics
Government Organization
Other End-Users
6.4. Global Oral Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Polio Vaccine (OPV)
Rotavirus Vaccine
Oral Typhoid Vaccine
Oral Cholera Vaccine
6.5. Global Oral Vaccine Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inactivated Polio Vaccine (IPV)
Inactivated Cholera Vaccine
Inactivated Hepatitis A Vaccine
6.6. Global Oral Vaccine Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Protein Subunit Vaccines
Polysaccharide Vaccines
Conjugate Vaccines
6.7. Global Oral Vaccine Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
DNA Vaccines
RNA Vaccines
Virus-Like Particle (VLP) Vaccines
Recombinant Vector Vaccines

7. Oral Vaccine Market Regional And Country Analysis

7.1. Global Oral Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Oral Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oral Vaccine Market

8.1. Asia-Pacific Oral Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oral Vaccine Market

9.1. China Oral Vaccine Market Overview
9.2. China Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oral Vaccine Market

10.1. India Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oral Vaccine Market

11.1. Japan Oral Vaccine Market Overview
11.2. Japan Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oral Vaccine Market

12.1. Australia Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oral Vaccine Market

13.1. Indonesia Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oral Vaccine Market

14.1. South Korea Oral Vaccine Market Overview
14.2. South Korea Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oral Vaccine Market

15.1. Western Europe Oral Vaccine Market Overview
15.2. Western Europe Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oral Vaccine Market

16.1. UK Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oral Vaccine Market

17.1. Germany Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oral Vaccine Market

18.1. France Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oral Vaccine Market

19.1. Italy Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oral Vaccine Market

20.1. Spain Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oral Vaccine Market

21.1. Eastern Europe Oral Vaccine Market Overview
21.2. Eastern Europe Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oral Vaccine Market

22.1. Russia Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oral Vaccine Market

23.1. North America Oral Vaccine Market Overview
23.2. North America Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oral Vaccine Market

24.1. USA Oral Vaccine Market Overview
24.2. USA Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oral Vaccine Market

25.1. Canada Oral Vaccine Market Overview
25.2. Canada Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oral Vaccine Market

26.1. South America Oral Vaccine Market Overview
26.2. South America Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oral Vaccine Market

27.1. Brazil Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oral Vaccine Market

28.1. Middle East Oral Vaccine Market Overview
28.2. Middle East Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oral Vaccine Market

29.1. Africa Oral Vaccine Market Overview
29.2. Africa Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oral Vaccine Market Competitive Landscape And Company Profiles

30.1. Oral Vaccine Market Competitive Landscape
30.2. Oral Vaccine Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

31. Oral Vaccine Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. GlaxoSmithKline Plc
31.3. Sinovac Biotech Ltd.
31.4. Panacea Biotec Ltd.
31.5. Emergent BioSolutions Inc.
31.6. Zydus Lifesciences
31.7. Serum Institute of India Pvt. Ltd.
31.8. Bharat Biotech Ltd.
31.9. Adimmune
31.10. Haffkine Biopharmaceutical Co. Ltd.
31.11. Changchun BCHT Biotechnology Co.
31.12. BIBCOL
31.13. Medigen Vaccine Biologics Corp.
31.14. BlueWillow Biologics Inc.
31.15. BioNet Asia Co. Ltd.

32. Global Oral Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oral Vaccine Market

34. Recent Developments In The Oral Vaccine Market

35. Oral Vaccine Market High Potential Countries, Segments and Strategies

35.1 Oral Vaccine Market In 2029 - Countries Offering Most New Opportunities
35.2 Oral Vaccine Market In 2029 - Segments Offering Most New Opportunities
35.3 Oral Vaccine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer